Historical record - last NADAC publication: 5/22/2019
Product Information
LEVETIRACETAM 250 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0828 per EA under NDC 76282024612. Its NADAC has been published 287 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282024612
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/22/2019
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA078234On Market Since
1/15/2009
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 250 MG TABLET has been published 287 times since Nov 28, 2013, and over the history we have for it it has declined 32.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0828 per EA |
|---|---|
| All-time high | $0.1732 (Feb 12, 2014) |
| All-time low | $0.0712 (Apr 17, 2019) |
| Median price | $0.0910 |
| Average price | $0.0949 |
| Largest weekly change | +35.2% (Jan 22, 2014) |
| Weeks tracked | 287 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 16 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 250 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0828 per EA (NDC 76282024612), effective May 22, 2019.
How has the price of LEVETIRACETAM 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 250 MG TABLET has declined 32.7%. It has been tracked across 287 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 250 MG TABLET?
Since Nov 28, 2013, the NADAC for LEVETIRACETAM 250 MG TABLET has ranged from a low of $0.0712 (Apr 17, 2019) to a high of $0.1732 (Feb 12, 2014), with a median of $0.0910 per EA.
Are there cheaper alternatives to LEVETIRACETAM 250 MG TABLET?
Yes. 16 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEVETIRACETAM 250 MG TABLET, is $0.0494 per EA — about 40% below LEVETIRACETAM 250 MG TABLET.
Who manufactures LEVETIRACETAM 250 MG TABLET?
LEVETIRACETAM 250 MG TABLET (NDC 76282024612) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification